Business News
Cannabis Products Lack Safety Labels, Use Kid-Friendly Packaging, Study Finds
A new study published in the American Journal of Preventive Medicine reveals that cannabis products sold in unlicensed retail shops often lack essential health and safety labels, and many feature colorful, cartoon-like packaging designed to attract children. The analysis compared 88 cannabis products from licensed and unlicensed New York City retailers and uncovered striking differences. Only about 1 in 30 of unlicensed cannabis products carried all six of New York State’s required health warnings and safety features, compared to roughly half of licensed products. Most unlicensed products did not list their THC potency, and nearly all provided no dosage guidance. “This study reveals a serious gap in regulation that puts consumers at risk,” said Dr. Ryan Sultan, a Columbia University child psychiatrist and co-author of the study, “We need coordinated action at both the state and federal levels to ensure cannabis product safety and to rein in misleading packaging.” By contrast, all licensed products in the sample disclosed THC content and about half included a standard dose indication. Many unlicensed packages even displayed official-looking symbols from other states, for example, California’s universal cannabis symbol, or included warnings about delayed effects meant for edibles, even when the product was not an edible. The researchers note that such mislabeling could give consumers a false sense of security about unregulated products. “Misleading or incomplete labels can lead to real harm, because consumers may not know what they’re actually getting,” said Dr. Tim Becker, Cornell psychiatrist and the study’s lead author. “It’s especially troubling to see how many products were clearly designed to catch the eye of kids or teens –that’s a public health concern we can’t ignore.” Another key finding was the prevalence of youth-oriented branding on cannabis packaging. Nearly all of products examined had elements likely to appeal to minors, such as bright, multicolored designs, playful fonts, or cartoon imagery. This trend was even more pronounced in unlicensed items: about 1 in 4 of unlicensed packages featured cartoon characters or graphics, versus 0% of licensed products. In New York, regulations prohibit marketing to minors, making these findings especially alarming. Cannabis use for minors has been associated with depression , ADHD , and anxiety . About Integrative Psychiatry is a mental health practice led by Dr. Ryan Sultan. The clinic provides comprehensive psychiatric and therapeutic services for children, adolescents, and adults, utilizing a holistic, evidence-based approach tailored to each individual’s unique needs. From ADHD , anxiety , and depression treatment to OCD , addiction , and trauma therapy, Integrative Psych’s multidisciplinary team provides personalized care to help clients achieve long-term well-being. Social Links LinkedIn Media Contact Full Name: Ryan Sultan Title: Integrative Psychiatrist Company Name: Integrative Psychiatry of Manhattan Website: https://www.integrative-psych.org
HEALTHandMED Highlights Whole Body Vibration System in Commitment to Noninvasive Wellness
HEALTHandMED Adds IonizeMe Machines to Its Product Range
HEALTHandMED Highlights GForce Pro Total Body Vibration Machine for Whole-Body Wellness
- July 29, 2025Medicine & Pharmaceuticals
HEALTHandMED Highlights the GForce Pro 1500W Dual Motor Whole Body Vibration Machine for High-Performance Wellness
HEALTHandMED is spotlighting its GForce Pro 1500W Dual Motor Whole Body Vibration Exercise Machine as a long-trusted wellness solution engineered for passive fitness and full-body conditioning. The platform is designed for high-demand users—from physical therapy centers and senior facilities to health-conscious individuals seeking reliable, results-driven equipment. "Many platforms focus on gimmicks, but we built the GForce Pro to deliver consistent outcomes in real-world use," said a spokesperson for HEALTHandMED. "Whether for rehab patients, active seniors, or busy clinics, this system offers measurable functionality—not just convenience." Built for resilience, the GForce Pro leads the market in whole-body vibration machine comparisons with a heavy-duty steel frame, large 27" x 20" plate, and dual motor design. Oscillation, also known as pivotal vibration, supports balance, lymphatic drainage, and reflex stimulation. In contrast, tri-planar vertical vibration helps engage deeper muscles, supporting bone health, strength, and muscle tone. Together, these vibration modes offer 60 adjustable speed levels and nine workout programs, including user-defined custom settings. This flexibility enables users to tailor sessions for relaxation, rehab, or muscle activation without stressing joints. Included arm bands enhance upper-body engagement, while the platform supports up to 400 lbs—ideal for clinics and high-use environments. A full exercise chart comes standard with the machine, covering 26 structured activities from stretching and strength-building to core work. This, along with online training resources, allows users to create a balanced wellness routine without the need for a full gym setup. With upgraded noiseless motors, simplified digital controls, and advanced programming modes, the GForce Pro is trusted by users looking for function, durability, and adaptability. Its dual-motion design enables users to alternate between recovery-based sessions and more intense conditioning protocols, all within a single unit.
- July 29, 2025Medicine & Pharmaceuticals
HEALTHandMED Enhances Ionic Detox Capabilities with IonizeMe Maxx System
HEALTHandMED, a supplier of health technology equipment specializing in the ionic foot detox sector, has added the IonizeMe Maxx Ionic Detox Foot Bath System to its product lineup. The equipment is engineered to offer a high-output 20-volt, 2.5-amp direct current system intended to support individuals in managing and maintaining their detox regimens. Built in the USA, the IonizeMe Maxx foot bath system utilizes increased electrical output to promote electrolysis and ionization principles. This system is designed with an adjustable output mechanism, and a voltage and amperage display that allows users to assess operational levels during use. For those interpreting session outcomes, tools like the ionic foot detox color chart can complement the system’s performance features by helping users understand visual changes in the water during a detox session. “The IonizeMe Maxx was designed with a focus on both performance and transparency,” said a spokesperson for HEALTHandMED. “Users can monitor the real-time voltage and amperage to help ensure they are getting accurate output from the system. This is a significant factor, as many similar systems in the market may display fixed or inaccurate readings.” Ionic detox foot baths function by producing charged ions in water, which proponents suggest may assist the body in releasing unwanted substances. While research on the therapeutic effectiveness remains varied, systems like the IonizeMe Maxx offer tools for those committed to detox practices and routines. The added functionality of monitoring array performance via the voltage display may contribute to more consistent usage and user awareness. “Our customers frequently seek clarity when interpreting detox session outcomes, and features like accurate voltage readings paired with resources such as the ionic foot detox color chart can help guide those interpretations,” the spokesperson added. HEALTHandMED continues to provide support tools, arrays, and replacement accessories for individuals using ionic foot detox systems. The IonizeMe Maxx is part of this broader product range, which aligns with the company’s commitment to supplying technology-based wellness tools. Disclaimer: These statements have not been evaluated by the FDA. The Ionic Detox System is not intended to diagnose, treat, cure, or prevent any disease.
- July 28, 2025Business
Dionysus Health and Mammha Announce Groundbreaking Partnership to Transform Postpartum Depression Care Through Precision Diagnostics and Comprehensive Support
Dionysus Health, the molecular diagnostics company behind myLuma ™, and Mammha , a leading provider of accessible, full-spectrum perinatal mental health care, today announced a groundbreaking partnership to fundamentally reshape how postpartum depression (PPD) is predicted, prevented, and treated. This first-of-its-kind collaboration combines myLuma™—the first predictive prenatal blood test for postpartum depression risk—with Mammha’s clinician-designed care platform, delivering the most complete and proactive maternal mental health solution on the market. myLuma™ is the first clinically validated molecular diagnostic that predicts a woman’s risk of PPD with 85% accuracy from a simple third-trimester blood draw. This allows providers to intervene as early as 28 weeks into pregnancy—weeks to months before symptoms may appear. Combined with Mammha’s full continuum of care, the partnership ensures mothers are not only identified early but supported throughout their entire maternal journey. “This partnership brings together scientific innovation and clinical care to deliver a true end-to-end solution,” said Dr. Andrea Cubitt, CEO of Dionysus Health. “myLuma™ provides the critical early warning system through molecular diagnostics, while Mammha ensures timely care delivery. We’re moving from reactive treatment to proactive prevention, from uncertainty to precision, and from fragmented efforts to coordinated care.” “We created Mammha to fill the gaps in the perinatal healthcare system that parents have been falling through for much too long,” said Maureen Fura, CEO of Mammha. “Partnering with Dionysus Health gives us the predictive power we’ve always dreamed of having, so that we can intervene early and effectively.” Why This Matters Now Postpartum depression is one of the most urgent and preventable maternal health crises: PPD contributes to almost 1 in 4 maternal deaths 75% of affected women receive no treatment The U.S. spends over $17 billion annually addressing the consequences 96% of U.S. counties face mental health provider shortages Only 33% of providers screen for perinatal depression (HEDIS) “We’re solving for OB providers, health systems, and mothers,” said Alisa Marie Beyer, COO of Dionysus Health. “While screening tools remain essential for identifying current symptoms, until now there’s been no biological diagnostic for PPD to predict risk before symptoms emerge. This partnership brings predictive data and enhanced support tools to enable proactive prevention, earlier intervention, and better outcomes for everyone involved.” Next Steps for Launch and Growth The integrated myLuma solution is projected to kick-off in September 2025 with a pilot program involving multiple OB providers across California and Florida, aiming for 100 completed patient tests per month. It is anticipated to grow the pilot to an additional 50 OB providers. The full-scale launch is planned for January 2026, targeting 100 provider offices and serving over 1,000 women monthly. Dionysus Health is currently managing a growing waitlist of providers and patients ahead of the national rollout. About Dionysus Health is a molecular diagnostics company focused on maternal mental health breakthroughs. The company developed MyLuma™, the first prenatal blood test that predicts postpartum depression risk with 85% accuracy, enabling personalized treatment and support for every mother. Dionysus Health’s mission is to replace delayed, self-reported screenings with clinically validated diagnostics that deliver reliable, early insights for patients, providers, and health systems. Mahmma is on a mission to provide a comprehensive, accessible perinatal mental health solution. Created by clinicians and parents, Mahmma serves as the go-to solution for providers, health systems, hospitals, and NICUs to screen, refer, support, educate, and treat pregnant and postpartum women experiencing maternal mental health complications like depression and anxiety, and their families. Media Contact Full Name: Amy VanHaren Company Name: Dionysus Health Email: [email protected] Phone Number: 6513038777 Website: https://myluma.health/
- July 25, 2025Medicine & Pharmaceuticals
Creative Biolabs Expands Global Support in Viral Vector Design and Gene Therapy Research
With its experience spanning decades in virology and molecular engineering, Creative Biolabs offers a full scope of customized services for viral vector construction , including adenovirus, herpes simplex virus (HSV), and other platforms capable of meeting different demands of basic and preclinical studies. It has never been easier for researchers globally who require high-efficiency gene delivery systems. Precision-Engineered Viral Vectors for Breakthrough Therapies The viral vector design platform of Creative Biolabs enables researchers to overcome the most significant challenges facing gene delivery, such as cellular uptake, immune evasion, and long-term expression. The company's proprietary technologies are applicable for the construction of integrating and non-integrating vectors with flexibility in applications for therapy. Adenovirus Vectors : With high transduction efficiency and capacity for large packaging, Creative Biolabs' adenoviral vectors are best suited for short-term gene expression and vaccine induction. First-, second-, and third-generation adenoviral systems, as well as helper-dependent vectors with improved safety profiles, are provided by the company. Herpes Simplex Virus Vectors : HSV vectors are well-suited to transducing neuronal cells and neurogenic neoplasias. With a high packaging capability of more than 30 kb and the ability to establish long-term gene expression without genomic integration, HSV vectors are a very potent instrument for the treatment of neurological disorders such as Alzheimer's and Parkinson's disease. Custom Design & Construction: From promoter engineering to gene knockout strategies, Creative Biolabs provides turnkey services for vector engineering, purification, and quality verification. Each project is tailored to the client's own research goals, with assurance of high titer, purity, and functional activity. Global Reach, Local Expertise Creative Biolabs is also pleased to offer its services to researchers on other continents with support and scalable production capabilities. Whether customers are conducting exploratory investigations or preparing Investigational New Drug (IND) submissions, the company's scientific team offers expert advisory and rapid turnaround. "Our mission is to make it possible for scientists to have the ability they need to push gene therapy forward," said a spokesperson for Creative Biolabs. "By making our viral vector platforms more affordable, we're accelerating breakthroughs around the world. About Creative Biolabs Creative Biolabs has been a committed partner in the development of gene therapy research, offering quality solutions in viral vector engineering, CRISPR delivery systems, and immunotherapy. Worldwide clientele and established scientific expertise have ensured the company remains at the vanguard of biotechnology and regenerative medicine innovation.
- July 24, 2025Medicine & Pharmaceuticals
Clifton, NJ Orthopedic Specialist For Spine & Joint Pain Relief: Services Expand
The orthopedic specialist clinic has expanded its services at 777 Passaic Avenue in Clifton, providing patients across Passaic County with faster access to specialized treatment for spine, joint, and sports-related conditions. Its availability of same-week appointments aims to reduce wait times and address the shortage of orthopedic services in North Jersey. More details can be found at https://hessorthopedics.com/location/orthopedic-surgeon-clifton-new-jersey According to data from the Centers for Disease Control and Prevention (CDC), approximately 39% of adults in the United States reported back pain in the past three months. Back pain also accounts for up to 3% of all physician visits annually. This surge in cases has fueled demand for alternatives to opioid-based pain management and invasive surgical procedures. Hess Spine and Orthopedics offers both surgical and non-surgical treatments for common conditions such as herniated discs, sciatica, arthritis, and work-related injuries. Procedures are led by Dr. Samuel Hess and Dr. David Greenwald, who specialize in minimally invasive interventions and personalized pain management strategies. "Our goal is to treat pain at its source rather than simply managing symptoms," said a representative from Hess Spine and Orthopedics . "We combine advanced medical techniques with personalized care plans suited to each patient's recovery timeline." The clinic also works in partnership with local medical centers, including Mountainside Medical Center, to provide coordinated care throughout a patient's recovery journey. Treatment options include joint reconstruction, spine surgery, sports injury rehabilitation, and non-surgical alternatives. About Hess Spine and Orthopedics Hess Spine and Orthopedics is led by Dr. Samuel Hess, a board-certified orthopedic surgeon with over 20 years of experience. He previously served as medical director of spine and orthopedic services at Fawcett Memorial Hospital in Port Charlotte, Florida, where he was also chief of surgery. Dr. Hess specializes in disc replacements, sacroiliac joint fusions, and stem cell injections. Dr. David Greenwald brings over two decades of neurosurgical expertise and is the co-founder of Comprehensive MD in Fort Lauderdale. His clinical focus includes neurological pain conditions, migraine management, and traumatic brain injury treatment. The clinic serves patients from surrounding areas, including Montclair, Nutley, Bloomfield, and Paterson. To schedule a consultation, patients can visit the facility at 777 Passaic Avenue, Suite 575, Clifton, NJ 07012. Additional information is also available through their YouTube channel: https://www.youtube.com/@HessSpineandOrthopedics
- July 24, 2025Medicine & Pharmaceuticals
RPT Labs Expands Access to Walk-In Drug Tests in Arlington
RPT Labs now offers walk-in drug tests in Arlington , providing timely, confidential testing for individuals and employers—no appointment required. Designed to accommodate a wide range of testing needs, from pre-employment screenings and court-ordered testing to post-incident and personal screenings, this walk-in option brings convenience, reliability, and regulatory compliance to a region where flexible testing has often been limited. Located near major transit routes and local employers, the Arlington facility offers accessible drug testing services with minimal wait times and same-day results for many standard screenings. The walk-in model removes common barriers—such as delayed scheduling or coordination bottlenecks—and allows clients to complete their testing on their terms. This approach reflects RPT Labs’ broader commitment to meeting the real-world demands of the communities and industries it serves across Massachusetts. The availability of walk-in drug tests in Arlington aligns with the growing demand across the healthcare, construction, transportation, legal, and education sectors. Many industries require rapid and compliant testing to maintain certifications or employment eligibility, so ease of access is essential. RPT Labs has responded by expanding flexible service offerings without compromising accuracy, privacy, or professional standards. At the Arlington location, individuals can access a full range of screening options, including urine drug tests, hair follicle testing, and alcohol testing. All procedures are conducted under strict chain-of-custody protocols by certified professionals trained in both testing methodology and client care. Test results meet legal admissibility standards and are delivered with clear documentation and responsive support throughout the process. The walk-in format benefits a wide range of clients. Individuals facing legal deadlines, involved in custody cases, or managing recovery programs can access critical testing services without delay. For employers, this flexible option makes it easier to manage random screenings, return-to-duty requirements, or last-minute onboarding needs. The ability to walk in for a drug test in Arlington without prior scheduling supports a more responsive workplace environment, especially in safety-sensitive roles governed by DOT regulations or internal drug-free workplace policies. In addition to drug and alcohol screenings, RPT Labs offers DNA testing for legal, medical, and personal use. Clients in Arlington can access these services with the same walk-in convenience and confidentiality protocols. All testing data is protected under HIPAA and applicable state laws, with careful controls in place to ensure results are shared only with authorized parties. Beyond individual services, RPT Labs continues to support employers with long-term testing programs tailored to industry-specific compliance requirements. Services include mobile on-site testing, DOT-compliant screening, and emergency post-accident testing with 24/7 availability. These programs are designed in collaboration with employers to reduce operational disruptions while supporting regulatory alignment and workplace safety. RPT Labs’ trained staff and state-of-the-art lab infrastructure support every aspect of the walk-in experience—from intake to final reporting. Results are processed using advanced testing technology, ensuring accuracy and consistency with every sample. Clients receive timely notifications, detailed reports, and access to a dedicated support team that understands the importance of clear, compliant documentation. RPT Labs has built its reputation on precision, professionalism, and a customer-first approach. The decision to expand walk-in access in Arlington reflects a long-term focus on public health, workforce safety, and operational efficiency. By eliminating unnecessary delays and offering trusted services in a local, accessible format, the organization continues to make drug and alcohol testing more approachable for everyone, whether an HR manager handles a last-minute screening or an individual navigates legal requirements. As communities and employers continue to prioritize safety, accountability, and well-being, the need for accessible drug testing remains clear. RPT Labs meets that need with a model built around trust, discretion, and timely service, further solidifying its role as a leading resource for walk-in drug tests in Arlington and beyond. About RPT Labs: RPT Labs is your trusted source for comprehensive Drug and DNA testing solutions. Based in Massachusetts, we are proud to serve clients across the state and beyond with a steadfast commitment to excellence. At RPT Labs, we embody the values of customer service, integrity, knowledge, and a passion for the industry, ensuring that you receive the highest quality testing services tailored to your needs.
- July 23, 2025Medicine & Pharmaceuticals
MexicanRXpharm Expands Online Pharmacy Delivery Services to Enhance Access to Essential Medications
MexicanRXpharm, a well-established online pharmacy delivery service, has announced an expansion of its offerings to provide customers with easier access to a broad range of medications. The company delivers both prescription and over-the-counter medications, providing a convenient alternative for those unable to visit physical pharmacies due to mobility issues, busy schedules, or other constraints. The team at the firm emphasizes that through MexicanRXpharm’s online platform, customers can browse available medications, place orders, and have them delivered promptly to their preferred locations. A spokesperson for MexicanRXpharm stated, “ We are proud to be a trusted online drugstore in Mexico . At MexicanRXpharm, we are committed to offering our customers a broad selection of branded and generic medications, ensuring access to quality healthcare products with ease.” The team at the firm emphasizes that the expansion aims to improve accessibility and convenience by leveraging a user-friendly website designed to simplify the ordering process. MexicanRXpharm has implemented strict measures to guarantee accurate order processing and compliance with applicable pharmaceutical regulations. Additionally, the company has integrated secure payment options to protect customers’ financial information and established a dedicated customer support team to assist users with any inquiries or issues during their purchase experience. “Our priority is to provide reliable service with a seamless delivery system while maintaining the highest security standards in payment processing,” the company representative added. This service expansion strengthens MexicanRXpharm’s reputation as a dependable provider of pharmaceutical products and reinforces its position in the online healthcare market.
- July 23, 2025Medicine & Pharmaceuticals
MexicanRXpharm Announces Availability of Medication Access Through Its Platform
MexicanRXpharm has issued a statement confirming the continued availability of its online platform, which facilitates the purchase of medications through legal and regulated channels in Mexico. The platform offers a range of pharmaceutical products including treatments for various health conditions. The representative stated, “Our platform integrates pharmacies that operate within the regulatory framework, enabling customers to make informed decisions based on verified information.” The platform operates by connecting customers with licensed pharmacies and verified medication suppliers across Mexico. It supports purchasing options that comply with applicable regulations, ensuring access to medicines in line with established standards. The company facilitates transparency regarding medication availability, usage, and dosage information as provided by manufacturers. The platform’s structure allows customers to select medications after consulting with healthcare professionals when needed. The purchasing process includes clear documentation and shipment protocols to ensure medications are delivered in compliance with relevant health and safety regulations. Online discount pharmacies are among the options accessible through the platform, offering a model that aims to provide medications at prices regulated by Mexican health authorities. The company ensures that such options are transparent in terms of pricing and product origin. The service includes detailed product descriptions drawn directly from manufacturer data, including uses, recommended doses, and warnings. Customers are given information that aligns with Mexican health guidelines and requirements. The platform’s design supports ease of use and compliance, making the process of obtaining medications more accessible for those who require them. MexicanRXpharm has positioned itself to accommodate the needs of individuals seeking medication alternatives within Mexico’s regulated pharmaceutical market. MexicanRXpharm offers a platform that lists medications available through licensed pharmacies in Mexico. The listings include essential details such as indications, recommended dosages, and safety information as supplied by the manufacturers. The service facilitates the ordering process while adhering to local legal requirements and health regulations. The representative added, “Providing detailed and accurate product information remains a priority to assist users in understanding their medication options.” The organization provides a resource that consolidates information on pharmaceutical products and their availability, aiming to enhance accessibility to medications within Mexico. The platform also facilitates communication between customers and pharmacies, enabling streamlined access to medicines.
- July 23, 2025Medicine & Pharmaceuticals
Amerigo Scientific Introduces Gold Nanoparticles with High Reproducibility in Terms of Size, Dispersion and Shape
Amerigo Scientific, a life science supplier focused on providing critical products and services to biomedical and pharmaceutical communities, announces the availability of highly reproducible gold nanoparticles with precise control over size, dispersion, and shape. These nanoparticles are designed to meet the stringent demands of biomedical research, diagnostics, and nanotechnology applications. Gold nanoparticles (NPs) have been widely used in many different areas such as drug delivery, biosensing, imaging, and catalysis, because of their distinctive optical, electronic, and biocompatible properties. Yet, controlling reproducible particle properties is a challenge for scientists, in particular, uniform size distribution, shape, and colloidal stability. Amerigo Scientific can meet this need with superior batch-to-batch consistency of monodisperse gold nanoparticles. “Our gold nanoparticles are engineered to provide researchers with a dependable and reproducible tool for advancing their work in nanomedicine, diagnostics, and material sciences,” said a spokesperson for Amerigo Scientific. “By minimizing variability in nanoparticle properties, we help scientists achieve more accurate and reproducible results.” Key features of Amerigo Scientific’s gold nanoparticles : Precise Size Control: Available in diameters ranging from 5 nm to 200 nm, with tight size distribution (low polydispersity index). Controlled Morphology: Spherical, rod-shaped, and other custom geometries to suit specific experimental requirements. Excellent Dispersion Stability: Surface-functionalized options ( e.g. , citrate, PEG, streptavidin, and antibodies) ensure long-term stability in various buffers and biological media. High Purity and Consistency: Manufactured under stringent quality control to ensure reliable performance in sensitive applications. Applications include : Small (5 ~ 15 nm): immunoassays, light microscopy, high magnification TEM, microarray platforms, and biosensors. Medium (20 ~ 80 nm): lateral flow analysis, TEM and SEM, DNA detection, and SERRS. Large (100 ~ 250 nm): flow cytometry, and SERRS. Amerigo Scientific’s gold nanoparticles are available in various formulations, including unconjugated, functionalized, and fluorescent-labeled options, catering to diverse research needs. For more information, product specifications, or to place an order, visit Amerigo Scientific’s gold nanoparticles collection or contact their customer support team. About Amerigo Scientific Amerigo Scientific, as a recognized distributor in the United States, collaborates closely with leading manufacturers worldwide and invites cooperation from all companies and institutions in the area of reagents, kits, antibodies, and many other products for life science, biochemistry, and biotechnology. Its professional team is equipped with excellent technical support and thoughtful customer service. As most of its employees have earned a graduate (Ph.D. or M.S.) degree in life science, they can comprehend customers’ questions or concerns and are always ready to provide individualized customer service of high standards.
- July 23, 2025Medicine & Pharmaceuticals
Lumea Wins a 2025 Global Recognition Award for Advancing Cancer Diagnostics with Innovative Technology
Lumea , a digital pathology tech company, has been honored with a 2025 Global Recognition Award for its contributions to cancer diagnostics through advanced technological solutions. The award acknowledges the organization's approach to digital pathology and its measurable impact on worldwide medical outcomes. Founded by pathologists Drs. Matthew O. Leavitt and Jared Szymanski in 2013, Lumea modified the landscape of diagnosis through its comprehensive digital pathology suite, which integrates both cutting-edge hardware and sophisticated software solutions. Photo Courtesy of Lumea The firm's solutions have enabled millions of clinical specimen diagnoses internationally, demonstrating significant market reach and establishing new standards in diagnostic accuracy. Lumea's core mission is to deliver practical, affordable digital laboratory solutions that empower specialists and fundamentally improve diagnostics throughout international health systems. The acknowledgment highlights the entity's focus on addressing essential challenges in analysis while maintaining high clinical performance standards. Progressive Platforms Addressing Critical Medical Challenges Traditional diagnostic methods rely on outdated processes, including physically transporting glass slides and samples in formaldehyde, creating damage and data loss risks. Some of Lumea’s products address these essential challenges through inventive design that changes how medical professionals handle and analyze tissue specimens. The company's approach recognizes that each biopsy holds crucial information, requiring optimal sample care from the point of collection through final diagnosis. The BxBoard® system represents a fundamental improvement in tissue transport by replacing traditional biopsy transport bottles with modern solutions that reduce biohazard waste in histology laboratories by 136 percent and plastic waste by 83 percent. This system decreases formalin use by 89 percent, creating safer environments for medical professionals and reducing environmental impact within health facilities. This tech demonstrates how creative engineering can simultaneously address multiple challenges, improving clinical outcomes and workplace safety for health professionals. It also keeps needle-core biopsies flat, reducing linear variability on the final histologic slide. The BxChip® is another significant advancement in tissue analysis technology that enhances tissue representation on glass slides by increasing tissue surface area by an average of 14.5 percent and biopsy core length by 31.8 percent. This improvement has resulted in a 9.3 percent average increase in accurate tumor detection rates, delivering measurable benefits in patient outcomes across global healthcare systems. The innovation shows how thoughtful engineering can directly translate into life-saving improvements in diagnostic accuracy. Market Impact and Technological Progress: A Comprehensive Digital Pathology Suite Lumea's comprehensive platform goes beyond hardware solutions, including a progressive laboratory viewer, image management system, and an integrated digital analysis platform that provides experts with remote diagnostic capabilities. BxLink™ is Lumea's proprietary Laboratory Information System (LIS) and digital pathology suite, specifically designed as a "one-stop shop" for everything related to urology. It streamlines the entire workflow, from specimen accessioning and tracking to comprehensive case management and reporting. BxLink acts as a central hub, integrating all aspects of the digital pathology process, including image acquisition, viewing, analysis, and secure data storage. This integrated approach ensures seamless communication and efficiency for uropathologists, reducing manual errors and accelerating diagnostic turnaround times. Lumea’s Viewer+™ is an innovative image management system (IMS) digital pathology plug-in designed for seamless integration with any existing LIS. This means that laboratories and pathology groups can leverage Lumea's advanced viewing and analysis capabilities without overhauling their current LIS infrastructure. Its flexibility ensures that Lumea's digital pathology features are accessible to a wider range of healthcare providers, enhancing clinical efficiencies and providing superior diagnostic support. These tools enhance efficiency while providing access to machine learning and artificial intelligence technologies that support more accurate diagnoses. They also help address the urgent need for specialty expertise in rural, third-world, and other underserved areas around the world. The firm's approach to innovation emphasizes that genuine progress requires a complete rethinking of the entire diagnostic workflow to benefit every stakeholder, especially the patient. Industry Honor and Future Growth Alex Sterling from Global Recognition Awards highlighted the importance of the team's achievement in improving healthcare delivery. He states, "What distinguishes Lumea is its foundation as an entity created by medical professionals, for pathologists, ensuring that every improvement remains closely connected to real-world clinical needs rather than theoretical applications.” The comprehensive patent portfolio and demonstrated effect on over 2 million specimen diagnoses internationally represent a significant contribution to broad health progress. The company continues to extend its reach with plans to release pre-analytical technology for breast biopsies, further increasing its influence on oncology diagnosis and treatment across multiple oncological specialties. Initially focused on prostate malignancy, which affects an estimated 288,300 new cases annually in the United States alone, Lumea has since expanded its solutions to address multiple tumor types. This expansion makes advanced diagnostic capabilities available to pathology groups of all sizes worldwide, ensuring that current technology reaches healthcare providers regardless of their institutional size or geographic location. About Global Recognition Awards Global Recognition Awards is an international organization that recognizes exceptional companies and individuals who have significantly contributed to their industry.
- July 22, 2025Medicine & Pharmaceuticals
Medicines Mexico Expands Online Access to Essential and Anti-Fungal Medications
Medicines Mexico, a distinguished online pharmacy delivery service, is pleased to announce the expansion of its platform to include a broader range of essential medications, including anti-fungal medicines. This strategic enhancement aims to address the increasing demand for accessible and efficient healthcare solutions by providing customers with a comprehensive and reliable means to obtain both prescription and over-the-counter pharmaceuticals. A spokesperson for Medicines Mexico stated, “We are committed to offering our customers an extensive selection of high-quality branded and generic medications, facilitating convenient access to necessary healthcare products from the comfort of their homes. We are delighted to offer anti fungal medication in Mexico . ” The expanded service prioritizes direct-to-customer delivery, significantly improving convenience for individuals who face difficulties visiting traditional pharmacy locations due to mobility challenges, time limitations, or other constraints. Through its secure and user-friendly online platform, users can effortlessly browse available medications, place orders, and receive prompt delivery to their preferred addresses. Medicines Mexico has implemented rigorous protocols to guarantee precise order processing and strict adherence to all applicable regulatory standards. In addition, the platform incorporates secure payment systems and dedicated customer support services to guide users through every step of the ordering process. “Our dedication to reliability is exemplified by our seamless delivery operations and the security measures embedded within our payment options,” the company representative added. This expansion further reinforces Medicines Mexico’s standing as a trusted and dependable provider in the pharmaceutical sector, underlining its commitment to enhancing patient access to essential medications.
ALL NEWS
- From Advocacy to Industry Standard: How One Small Canadian Company's Laneway House Innovation Sparked 450 Weekly Permits in California 20 Years Later
- Yixin Unveils Conscious Events Conversion: A New Standard for Purpose-Driven Growth
- Formulation Factory Announces Launch of Self Obsessed Testosterone Booster
- Ken and Megan Gerber Launch "Cross Examined with The Gerbers" Podcast, Blending Law, Life, and Faith
- MandaFacil Launches Revolutionary Cross-Border E-Commerce Platform for U.S. Mexicans
- Front Porch Café Announces Franchise Expansion After 'The Blox'
- M Vincent Fansler Announces Speaking Appearance at USA National Association of Default Professionals Annual Meeting 2025
- Court Counseling Institute Announces Expansion of Court-Mandated Mental Health Programs to 21 Languages
- Xraised Selects Anthony Tse as a Top Career Coach for Leadership and Transformation
- Xraised Honours Shak Schiff: The Leading Force in Digital Assurance Excellence
- Emela Brace Nomolos Receives 2025 Best Legacy Award in Switzerland
- Los Angeles Cleaning Services Officially Launches to Serve Homes and Businesses Across LA
- Boerger Consulting Named Top Choice by Xraised for Software, Asset, and Compliance Leadership
- Marketing Expert Jaslyin Qiyu and Mad About Marketing Consulting Recognized by Xraised for Outstanding Strategy, Branding, and Innovation
- Xraised Names Bonsai Smart Wealth Founder Daniel Afan-Jones as a Leader in Finance Innovation
- Xraised Honors Niccola Milnes: From Global Strategy to Children’s Wellness
- Derrick Chevalier Recognized by Xraised as the Pinnacle of Negotiation, Strategy, and Leadership Excellence
- Turning Memories Into Diamonds: Saint Diamonds Announces How it Is Helping Families Keep Their Loved Ones Close
COMMUNICATE. COMMAND. COMMERCE.
Lead the conversation of your brand & win more customers with MarketersMEDIA Solutions.
Explore Now